Sign inGet started

Franson Timothy R

Insider CIK 1471650 · PRTK Director · CDTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PRTK Paratek Pharmaceuticals, I D To issuer deriv2023-09-212023-09-215,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer deriv2023-09-212023-09-217,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer deriv2023-09-212023-09-217,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer deriv2023-09-212023-09-215,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer deriv2023-09-212023-09-216,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer deriv2023-09-212023-09-2112,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer deriv2023-09-212023-09-2120,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer2023-09-212023-09-2120,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer2023-09-212023-09-2152,000— $020,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2023-06-222023-06-2342,500— $042,500SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2023-02-212023-02-237,000$1.88 $13.2K72,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2023-02-082023-02-0920,000— $079,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2022-06-222022-06-2428,000— $028,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2022-02-162022-02-1820,000— $059,000SEC↗
CDTX Cidara Therapeutics, Inc. P Buy2021-09-132021-09-147,000$2.12 $14.8K11,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2021-06-232021-06-2417,500— $017,500SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2021-02-182021-02-227,000— $07,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2021-02-182021-02-229,000— $039,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2020-06-252020-06-2517,500— $017,500SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2020-02-192020-02-217,000— $07,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2020-02-192020-02-219,000— $030,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2019-06-172019-06-2711,000— $011,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2019-02-262019-02-285,000— $05,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2019-02-262019-02-287,500— $021,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2018-06-132018-06-1511,000— $011,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2018-02-142018-02-165,000— $05,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-02-142018-02-167,500— $013,500SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2017-06-222017-06-2311,000— $011,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2017-02-022017-02-066,000— $06,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2017-02-022017-02-066,000— $06,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2016-06-222016-06-249,000— $09,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2016-02-042016-02-0812,000— $012,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2015-07-312015-08-0420,000— $020,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2015-06-092015-06-119,000— $09,000SEC↗
CDTX Cidara Therapeutics, Inc. P Buy2015-04-202015-04-214,000$16.00 $64.0K4,000SEC↗